18 September 2020 : Original article
ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Shih-Chao Hsu123ABCDEF, Ashok Thorat13ABCEF, Long-Bin Jeng143ABCDEF*, Ping-Chun Li135ADF, Te-Hung Chen123BCF, Horng-Ren Yang123BDE, Kin-Shing Poon36DFDOI: 10.12659/AOT.923502
Ann Transplant 2020; 25:e923502
Table 4 Characteristics of HCC patients.
| <UCSF (N=16) | >UCSF (N=11) | |
|---|---|---|
| Sex (Male: Female) | 9: 7 | 9: 2 |
| HBV related | 7 | 7 |
| HCV related | 5 | 2 |
| HBV+HCV | 1 | 0 |
| Non-B/non-C | 3 | 2 |
| AFP <200 | 16 | 7 |
| >1000 | 0 | 4 |
| MELD <20 | 14 | 10 |
| MELD >20 | 2 | 1 |
| Macro-vascular invasion(+) | 0 | 2 |
| Micro-vascular invasion(+) | 1 | 3 |
| TNM Stage I & II | 16 | 4 |
| TNM Stage III & > | 0 | 7 |
| Expired | 1 | 4 |